AAAAAA

   
Results: 1-3 |
Results: 3
HIGH-INCIDENCE OF ANTI-HEPARIN PLATELET FACTOR-4 ANTIBODIES AFTER CARDIOPULMONARY BYPASS-SURGERY/
Authors: TROSSAERT M GAILLARD A COMMIN PL AMIRAL J VISSAC AM
Citation: M. Trossaert et al., HIGH-INCIDENCE OF ANTI-HEPARIN PLATELET FACTOR-4 ANTIBODIES AFTER CARDIOPULMONARY BYPASS-SURGERY/, British Journal of Haematology, 101(4), 1998, pp. 653-655
HIGH-FREQUENCY OF ANTI-HEPARIN PF4 ANTIBODIES IN CARDIOPULMONARY BYPASS/
Authors: TROSSAERT M GAILLARD A COMMIN PL VISSAC AM AMIRAL J FRESSINAUD E
Citation: M. Trossaert et al., HIGH-FREQUENCY OF ANTI-HEPARIN PF4 ANTIBODIES IN CARDIOPULMONARY BYPASS/, Thrombosis and haemostasis, 1997, pp. 1835-1835
POSTOPERATIVE HEMOSTASIS AND FIBRINOLYSIS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS WITH OR WITHOUT APROTININ THERAPY
Authors: LU H DUBUIT C SORIA J TOUCHOT B CHOLLET B COMMIN PL CONSEILLER C ECHTER E SORIA C
Citation: H. Lu et al., POSTOPERATIVE HEMOSTASIS AND FIBRINOLYSIS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS WITH OR WITHOUT APROTININ THERAPY, Thrombosis and haemostasis, 72(3), 1994, pp. 438-443
Risultati: 1-3 |